A More Uniform Measurement of Factor VIII Inhibitors
Carol K. Kasper(University of Southern California), N. R. Shulman, D. Green, Louis M. Aledort(Icahn School of Medicine at Mount Sinai), MW Hilgartner, Peter H. Levine, Richard W. Counts, J. Holly D. Hampton, Jack Lazerson(Children's Hospital of Wisconsin), J A Penner, Jan van Eys, Sandor S. Shapiro(Harvard University), J. Roger Edson, David L. Aronson(George Washington University), Joseph C. Fratantoni, Campbell W. McMillan(University of North Carolina at Chapel Hill)
Cited by 587
Related Papers
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
|The Lancet|2008|862
Definitions in Hemophilia
|Thrombosis and Haemostasis|2001|772
A longitudinal study of orthopaedic outcomes for severe factor‐VIII‐deficient haemophiliacs
|Journal of Internal Medicine|1994|613
The effect of salicylates on the hemostatic properties of platelets in man
|Journal of Clinical Investigation|1968|539